Theratechnologies Kurs/ Buchwert
Was ist das Kurs/ Buchwert von Theratechnologies?
Kurs/ Buchwert von Theratechnologies Inc. ist 7.84
Was ist die Definition von Kurs/ Buchwert?
Kurs-Buchwert-Verhältnis repräsentiert das Verhältnis zwischen dem Aktienwert eines Unternehmens und dem Buchwert pro Aktie.
The price to book ratio, or P/B ratio, is a financial ratio used to compare a company's current market price to its book value. It is also sometimes known as a market to book ratio or price to equity ratio. The calculation of a price to book ratio can be performed in two ways. It can be calculated as the company's market capitalization divided by the company's total book value from its balance sheet. It can also be calculated using per-share values and dividing a company's current share price by the book value per share (i.e. its book value divided by the number of outstanding shares).
The P/B ratio varies between industries. The industries that require more infrastructure capital (for each dollar of profit) will usually trade at P/B ratios much lower than, for example, consulting firms. P/B ratios are commonly used to compare banks, because most assets and liabilities of banks are constantly valued at market values. A higher P/B ratio implies that investors expect management to create more value from a given set of assets, all else equal (and/or that the market value of the firm's assets is significantly higher than their accounting value).
P/B ratios do not, however, directly provide any information on the ability of the firm to generate profits or cash for shareholders. This ratio also gives some idea of whether an investor is paying too much for what would be left if the company went bankrupt immediately. For companies in distress, the book value is usually calculated without the intangible assets that would have no resale value. In such cases, P/B should also be calculated on a "diluted" basis, because stock options may well vest on sale of the company or change of control or firing of management.
Kurs/ Buchwert von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Theratechnologies
Was macht Theratechnologies?
theratechnologies inc., a biopharmaceutical company, markets prescription products in the united states, europe, and canada. it offers egrifta and egrifta sv, for the reduction of excess abdominal fat in human immunodeficiency virus (hiv)-infected patients with lipodystrophy; and trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant hiv-1 infected patients. the company's pipeline products include f8 formulation that could be used for the treatment of hiv-associated lipodystrophy; th-1902 for the treatment of triple negative breast cancer; and th-1904 for the treatment of ovarian cancer. the company was founded in 1993 and is headquartered in montreal, canada.
Unternehmen mit kurs/ buchwert ähnlich Theratechnologies
- Eminent Gold hat Kurs/ Buchwert von 7.83
- Compania de Distribucion Integral Logista S.A hat Kurs/ Buchwert von 7.83
- SML Isuzu hat Kurs/ Buchwert von 7.83
- Varian Medical Systems hat Kurs/ Buchwert von 7.84
- Eagle Mountain Mining hat Kurs/ Buchwert von 7.84
- Wisetech Global hat Kurs/ Buchwert von 7.84
- Theratechnologies hat Kurs/ Buchwert von 7.84
- Gran Tierra hat Kurs/ Buchwert von 7.84
- China Baofeng (International) hat Kurs/ Buchwert von 7.84
- Koolearn Technology hat Kurs/ Buchwert von 7.84
- eXp World Inc hat Kurs/ Buchwert von 7.85
- Firstsource Solutions hat Kurs/ Buchwert von 7.85
- Rimbaco Grp Global Ltd hat Kurs/ Buchwert von 7.85